碳青霉烯耐药肺炎克雷伯菌的耐药与传播机制研究进展及对策

doi:10.16150/j.1671-2870.2018.06.001

摘要/Abstract

中图分类号:

R378.99⁺6

蒋晓飞, 周迎. 碳青霉烯耐药肺炎克雷伯菌的耐药与传播机制研究进展及对策[J]. 诊断学理论与实践, 2018, 17(06): 623-629.

[1] Patel G, Bonomo RA.Status report on carbapenemases: challenges and prospects[J]. Expert Rev Anti Infect Ther,2011,9(5):555-570.
[2] Tzouvelekis LS, Markogiannakis A, Psichogiou M, et al.Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions[J]. Clin Microbiol Rev,2012,25(4):682-707.
[3] Centers for Disease Control and Prevention (CDC). Vital signs: carbapenem-resistant Enterobacteriaceae[J]. Morb Mortal Wkly Rep,2013,62(9):165-170.
[4] Hu F, Chen S, Xu X, et al.Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai, China[J]. J Med Microbiol, 2012,61(Pt 1):132-136.
[5] Giani T, Pini B, Arena F, et al. Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June2011[J]. Euro Surveill,2013,18(22):pii20489.
[6] Pollett S, Miller S, Hindler J, et al.Phenotypic and molecular characteristics of carbapenem-resistant Enterobacteriaceae in a health care system in Los Angeles, California, from 2011 to 2013[J]. J Clin Microbiol, 2014, 52(11):4003-4009.
[7] Pitout JD, Nordmann P, Poirel L,Poirel L.Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance[J]. Antimicrob Agents Chemother,2015,59(10):5873-5884.
[8] Grundmann H, Glasner C, Albiger B, et al.Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae(EuSCAPE): a prospective, multinational study[J]. Lancet Infect Dis,2017,17(2):153-163.
[9] Chen L, Mathema B, Chavda KD, et al.Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding[J]. Trends Microbiol,2014,22(12):686-696.
[10] Partridge SR, Kwong SM, Firth N, et al.Mobile Genetic Elements Associated with Antimicrobial Resistance[J]. Clin Microbiol Rev,2018,31(4):e00088-17.
[11] Qin S, Fu Y, Zhang Q, et al.High incidence and ende-mic spread of NDM-1-positive Enterobacteriaceae in Henan Province, China[J]. Antimicrob Agents Chemother,2014,58(8):4275-4282.
[12] Datta S, Roy S, Chatterjee S, et al.A five-year experie-nce of carbapenem resistance in Enterobacteriaceae causing neonatal septicaemia: predominance of NDM-1[J]. PLoS One,2014,9(11):e112101.
[13] Jin Y, Shao C, Li J, et al.Outbreak of multidrug resistant NDM-1-producing Klebsiella pneumoniae from a neonatal unit in Shandong Province, China[J]. PLoS One,2015,10(3):e0119571.
[14] Xie L, Dou Y, Zhou K, et al.Coexistence of blaOXA-48 and Truncated blaNDM-1 on Different Plasmids in a Klebsiella pneumoniae Isolate in China[J]. Front Microbiol,2017,8:133.
[15] Lu MC, Tang HL, Chiou CS, et al.Clonal dissemination of carbapenemase-producing Klebsiella pneumoniae: Two distinct sub-lineages of Sequence Type 11 carrying blaKPC-2 and blaOXA-48[J]. Int J Antimicrob Agents,2018,52(5):658-662.
[16] Chen C M, Guo M K, Ke S C, et al.Emergence and nosocomial spread of ST11 carbapenem-resistant Klebsiella pneumoniae co-producing OXA-48 and KPC-2 in a regional hospital in Taiwan[J]. J Med Microbiol,2018.
[17] Guo L, An J, Ma Y, et al.Nosocomial Outbreak of OXA-48-Producing Klebsiella pneumoniae in a Chinese Hospital: Clonal Transmission of ST147 and ST383[J]. PLoS One, 2016,11(8):e160754.
[18] Rodríguez-Baño J, Gutiérrez-Gutiérrez B, Machuca I, et al. Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-,Carbapenemase-Producing Enterobacteriaceae[J]. Clin Microbiol Rev,2018,31(2):piie00079-17.
[19] Zhang Y, Jiang X, Wang Y, et al.Contribution of β-lactamases and porin proteins OmpK35 and OmpK36 to carbapenem resistance in clinical isolates of KPC-2-producing Klebsiella pneumoniae[J]. Antimicrob Agents Chemother,2014,58(2):1214-1217.
[20] Jiang Y, Yu D, Wei Z, et al.Complete nucleotide sequence of Klebsiella pneumoniae multidrug resistance plasmid pKP048, carrying blaKPC-2, blaDHA-1, qnrB4, and armA[J]. Antimicrob Agents Chemother,2010,54(9):3967-3969.
[21] Xiang DR, Li J J, Sheng Z K, et al.Complete Sequence of a Novel IncR-F33:A-:B- Plasmid, pKP1034, Harboring fosA3, blaKPC-2, blaCTX-M-65, blaSHV-12, and rmtB from an Epidemic Klebsiella pneumoniae Sequence Type 11 Strain in China[J]. Antimicrob Agents Chemother,2015,60(3):1343-1348.
[22] Leavitt A, Chmelnitsky I, Carmeli Y, et al.Complete nucleotide sequence of KPC-3-encoding plasmid pKpQIL in the epidemic Klebsiella pneumoniae sequence type 258[J]. Antimicrob Agents Chemother,2010,54(10):4493-4496.
[23] García-Fernández A, Villa L, Carta C, et al.Klebsiella pneumoniae ST258 producing KPC-3 identified in italy carries novel plasmids and OmpK36/OmpK35 porin variants[J]. Antimicrob Agents Chemother,2012,56(4):2143-2145.
[24] Adler A, Paikin S, Sterlin Y, et al.A swordless knight: epidemiology and molecular characteristics of the blaKPC-negative sequence type 258 Klebsiella pneumoniae clone[J]. J Clin Microbiol,2012,50(10):3180-3185.
[25] Tang Y, Li G, Liang W, et al. Translocation of Carbapenemase Gene blaKPC-2 both Internal and External to Transposons Occurs via Novel Structures of Tn1721 and Exhibits Distinct Movement Patterns[J]. Antimicrob Agents Chemother, 2017,61(10):piie01151-17.
[26] Shen P, Zhang Y, Li G, et al.Characterization of the genetic environment of the blaKPC-2 gene among Klebsiella pneumoniae isolates from a Chinese Hospital[J]. Braz J Infect Dis,2016,20(4):384-388.
[27] Mathers AJ, Peirano G, Pitout JD.The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae[J]. Clin Microbiol Rev,2015,28(3):565-591.
[28] Chen L, Mathema B, Pitout JD, et al.Epidemic Klebsiella pneumoniae ST258 is a hybrid strain[J]. MBio,2014,5(3):e01355-14.
[29] Chen L, Mathema B, Chavda KD, et al.Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding[J]. Trends Microbiol,2014,22(12):686-696.
[30] Yosef I, Qimron U.Microbiology: How bacteria get space-rs from invaders[J]. Nature,2015,519(7542):166-167.
[31] Gu D, Dong N, Zheng Z, et al.A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumo-niae in a Chinese hospital: a molecular epidemiological study[J]. Lancet Infect Dis,2018,18(1):37-46.

碳青霉烯耐药肺炎克雷伯菌的耐药与传播机制研究进展及对策

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	陈宏, 沈银忠. 人类免疫缺陷病毒感染/艾滋病合并结核病的诊治进展[J]. 诊断学理论与实践, 2022, 21(04): 530-534.
[2]	汤建平, 龚邦东. 干燥综合征的诊治现状、挑战和思考[J]. 诊断学理论与实践, 2022, 21(03): 291-298.
[3]	李丽, 朱咏臻, 周敏, 钱嘉, 方丽莉. 2017年至2021年上海嘉定区某医院多重耐药菌分析[J]. 诊断学理论与实践, 2022, 21(01): 62-67.
[4]	罗雅方, 徐倩玥, 余红. 尘螨在特应性皮炎中的致病机制及相关免疫治疗应用研究进展[J]. 诊断学理论与实践, 2021, 20(06): 592-595.
[5]	苏长青. 从基础研究到临床转化应用谈肝癌的诊治进展[J]. 诊断学理论与实践, 2021, 20(05): 427-433.
[6]	陈华, 刘锦燕, 李文静, 赵珺涛, 项明洁. 新型咪唑类药物2-咪唑-2,4-戊二烯酮19和44对白念珠菌抗菌效果和作用机制初步研究[J]. 诊断学理论与实践, 2021, 20(04): 356-361.
[7]	章淼滢, 罗飞宏. 儿童单基因糖尿病诊治进展及诊断策略[J]. 诊断学理论与实践, 2021, 20(03): 229-232.
[8]	王院霞, 姚锂凤, 郑巧平, 陈旭. 9株分离自住院患者的CA-MRSA基因型菌株的分子特征及耐药性研究[J]. 诊断学理论与实践, 2021, 20(01): 66-70.
[9]	王安琪, 王士礼, 郎军添, 向明亮. 224例慢性化脓性中耳炎患者耳分泌物培养结果及多重耐药菌感染分析[J]. 诊断学理论与实践, 2021, 20(01): 88-92.
[10]	孔娜娜, 张培燕, 杨德平, 金慧敏, 郑江花. 上海周浦地区2016年至2020年尿路感染者病原体分布情况及耐药性检测[J]. 诊断学理论与实践, 2021, 20(01): 93-97.
[11]	徐兆平, 王浩飞. ZNF692基因在肾透明细胞癌中的表达及其与患者预后间关系的研究[J]. 诊断学理论与实践, 2020, 19(03): 292-296.
[12]	余红, 王一飞, 陈佳, 陈洁, 李斌. 青蒿素及其衍生物在皮肤疾病中的作用机制研究及临床应用[J]. 诊断学理论与实践, 2019, 18(2): 233-236.
[13]	魏坚, 高平进, 韩卫青. α7烟碱型乙酰胆碱受体激动剂对TGF-β1介导的血管外膜成纤维细胞表型转化影响的体外研究[J]. 诊断学理论与实践, 2019, 18(1): 56-60.
[14]	房莹, 吴东, 常春康. 癌基因与抑癌基因在伯基特淋巴瘤发生发展中的研究进展[J]. 诊断学理论与实践, 2019, 18(06): 630-633.
[15]	刁文晶, 皇甫昱婵, 朱威南, 刘婧娴, 刘瑛, 沈立松. 耐碳青霉烯类大肠埃希菌临床分离情况及碳青霉烯酶基因研究[J]. 诊断学理论与实践, 2019, 18(06): 655-661.